glp-1 testosterone levels study Scientists say a popular class of weight loss and diabetes drugs may also have unexpected benefits for male reproductive health. A new suggests that medications could improve levels, sperm Health Rounds: GLP-1 obesity drugs

March 4, 2025 New NAION Study A recent study in JAMA Ophthalmology explored the potential link between semaglutide and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden vision loss

Mace et al

Consumer insights shaping GLP-1 food products Consumer research highlights several patterns shaping product development

Among those who have used GLP-1 drugs, about half report they have experienced nausea and about one-third experienced diarrhea the two most-common side effects associated with the medications

The phase 2 study to evaluate the efficacy, safety and tolerability of maridebart cafraglutide is currently ongoing (ClinicalTrials.gov number, NCT05669599)